Related content

The role of anticyclic citrullinated peptide antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica

By Ceccato F.   Roverano S.   Barrionuevo A.   Rillo O.   Paira S.  

Clinical Rheumatology, Vol. 25, Iss. 6, 2006-11 ,pp. : 854-857

Springer Publishing Company

Access to resources Recommend Favorite

Second generation anti-cyclic citrullinated peptide (anti-CCP2) antibodies can replace other anti-filaggrin antibodies and improve rheumatoid arthritis diagnosis

By Grootenboer-Mignot S   Nicaise-Roland P   Delaunay C   Meyer O   Chollet-Martin S   Labarre C  

Scandinavian Journal of Rheumatology, Vol. 33, Iss. 4, 2004-07 ,pp. : 218-220

Informa Healthcare

Access to resources Recommend Favorite

Antibodies against cyclic citrullinated peptide (CCP) and levels of cartilage oligomeric matrix protein (COMP) in very early arthritis: relation to diagnosis and disease activity

By Söderlin MK   Kastbom A   Kautiainen H   Leirisalo-Repo M   Strandberg G   Skogh T  

Scandinavian Journal of Rheumatology, Vol. 33, Iss. 3, 2004-05 ,pp. : 185-188

Informa Healthcare

Access to resources Recommend Favorite

Predictive value of antibodies to cyclic citrullinated peptide in patients with early arthritis

By Ateş Aşkın   Karaaslan Yaşar   Aksaray Sebahat  

Clinical Rheumatology, Vol. 26, Iss. 4, 2007-04 ,pp. : 499-504

Springer Publishing Company

Access to resources Recommend Favorite

Citrulline and anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis

By Yamada Ryo   Suzuki Akari   Yamamoto Kazuhiko  

Future Rheumatology, Vol. 1, Iss. 2, 2006-04 ,pp. : 249-258

Future Medicine

Access to resources Recommend Favorite